4-Bromophenylboronic Acid
Suppliers
Names
[ CAS No. ]:
5467-74-3
[ Name ]:
4-Bromophenylboronic Acid
[Synonym ]:
4-Bromophenylboronic Acid
Boronic acid, B-(4-bromophenyl)-
(4-Bromophenyl)boronic acid
EINECS 226-779-9
MFCD00002104
p-bromophenylboronic acid
Chemical & Physical Properties
[ Density]:
1.7±0.1 g/cm3
[ Boiling Point ]:
315.0±44.0 °C at 760 mmHg
[ Melting Point ]:
284-288 °C(lit.)
[ Molecular Formula ]:
C6H6BBrO2
[ Molecular Weight ]:
200.826
[ Flash Point ]:
144.3±28.4 °C
[ Exact Mass ]:
199.964417
[ PSA ]:
40.46000
[ LogP ]:
2.36
[ Vapour Pressure ]:
0.0±0.7 mmHg at 25°C
[ Index of Refraction ]:
1.598
[ Storage condition ]:
0-6°C
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- CY8650000
- CHEMICAL NAME :
- Benzeneboronic acid, p-bromo-
- CAS REGISTRY NUMBER :
- 5467-74-3
- BEILSTEIN REFERENCE NO. :
- 2936347
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C6-H6-B-Br-O2
- MOLECULAR WEIGHT :
- 200.84
- WISWESSER LINE NOTATION :
- QBQR DE
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 180 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CSLNX* U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) Volume(issue)/page/year: NX#03201
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H315-H319-H335
[ Precautionary Statements ]:
P261-P305 + P351 + P338
[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves
[ Hazard Codes ]:
Xi:Irritant
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S26-S36-S37/39
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
CY8650000
[ HS Code ]:
2931900090
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2931900090
[ Summary ]:
2931900090. other organo-inorganic compounds. VAT:17.0%. Tax rebate rate:13.0%. Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward). MFN tariff:6.5%. General tariff:30.0%
Articles
J. Pharm. Sci. 104(4) , 1311-8, (2015)
In vitro lipolysis experiments are used to assess digestion of lipid-based formulations, and probe solubilisation by colloidal phases during digestion. However, proteins and other biological component...
Langmuir 31 , 6933-41, (2015)
Liquid crystalline nanoparticles have shown great potential for application in fields of drug delivery and agriculture. However, optimized approaches to generating these dispersions have long been sou...
Pharm. Res. 31(6) , 1536-52, (2014)
To explore the possibility that age-related changes in physiology may result in differences in drug bioavailability after oral administration of lipid based formulations of danazol.Danazol absorption ...